District Court Issues Favorable Ruling and Denies United Therapeutics’ Request to Block YUTREPIA™ Launch Judge Andrews denied the motion for preliminary injunction filed by United Therapeutics that sought to block the launch of Liquidia’s YUTREPIA™.

Liquidia Corporation Reports First Quarter 2024 Financial Results and Provides Corporate Update Liquidia Corporation (NASDAQ: LQDA) today reported financial results for the first quarter ended March 31, 2024.